Arich Enterprise Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 10, 2021
Share
Arich Enterprise Co., Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was TWD 228.969 million compared to TWD 279.745 million a year ago. Operating income was TWD 11.948 million compared to TWD 13.017 million a year ago. Net income was TWD 9.762 million compared to TWD 20.415 million a year ago. Basic earnings per share was TWD 0.13 compared to TWD 0.3 a year ago. For the half year, total revenue was TWD 472.554 million compared to TWD 670.390 million a year ago. Operating income was TWD 24.357 million compared to TWD 34.803 million a year ago. Net income was TWD 21.265 million compared to TWD 36.485 million a year ago. Basic earnings per share was TWD 0.29 compared to TWD 0.65 a year ago. Diluted earnings per share was TWD 0.28 compared to TWD 0.65 a year ago.
Arich Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the sales and marketing of pharmaceuticals, as well as the provision of the related logistics services. The Company is principally engaged in the sale and marketing of prescription drugs for gynaecology, obstetrics, urinary, derma and ophthalmology use; guideline drugs for hair breeding, intestines and stomach and smoking quit, as well as health consumer goods for oral health, daily consuming and beauty care, among others. The Company also provides distribution and logistics services for prescription drugs, guideline drugs, restriction drugs, cold chain drugs, clinical trial drugs and healthcare products, among others. The Company operates its business mainly within domestic market.
ARICH ENTERPRISE CO., LTD. 
